Anne Lespine
127
Documents
Publications
O75 | Pharmacodynamic and phenotypic evaluation of eprinomectin resistant Haemonchus isolates from French dairy sheep farms15th International Congress of the European Association for Veterinary Pharmacology and Toxicology, European Association of Veterinary Pharmacology and Toxicology (EAVPT), Jul 2023, Bruges, Belgium. pp.65-65, ⟨10.1111/jvp.13241⟩
Communication dans un congrès
hal-04181004v1
|
|
Anthelmintic Fluorescent drugs, new probes to detect anthelmintic resistance in the nematode Caenorhabditis elegansWAAVPT 2021, Jul 2021, Dublin (Online), France
Communication dans un congrès
hal-04169554v1
|
|
The transcription factor NHR-8 is involved in ivermectin tolerance in the model nematode Caenorhabditis elegans and in the strongylid nematode Haemonchus contortusanthelmintics: Discovery to resistance, Jan 2018, Clearwater, United States
Communication dans un congrès
hal-02929481v1
|
|
The transcription factor NHR-8 is involved in ivermectin tolerance in the model nematode Caenorhabditis elegans and in the strongylid nematode Haemonchus contortus26. International Conference of the World Association for the Advancement of Veterinary Parasitology (WAAVP 2017), The Malaysian Society of Parasitology & Tropical Medicine (MSPTM)., Sep 2017, Kuala Lumpur, Malaysia
Communication dans un congrès
hal-02736808v1
|
|
Discovery of a new factor involved in ivermectin tolerance in the model nematode Caenorhabditis elegans and in the strongylid nematode Haemonchus contortus.Molecular Helminthology: An Integrated Approach, Mar 2017, Cap Cod, United States
Communication dans un congrès
hal-02957851v1
|
|
ABCB1 is involved in vitamin D intestinal efflux16. Fat Soluble Vitamins (FSV) congress, Société Française des Vitamines et Biofacteurs (SFVB). FRA., Mar 2017, Paris, France. 130 p
Communication dans un congrès
hal-01517923v1
|
|
Comparison of ivermectin and moxidectin resistance profiles in the nematode Caenorhabditis elegansInternational Conference of the World Association for the Advancement of Veterinary Parasitology (WAAVP 2015), Aug 2015, liverpool, United Kingdom
Communication dans un congrès
hal-02929510v1
|
|
Comparative pharmacodynamics and pharmacokinetics of moxidectin and ivermectin endectocides: a brief update12. International Congress of the European Association for Veterinary Pharmacology and Toxicology (EAVPT 2012), Jul 2012, Noordwijkerhout, Netherlands. 182 p
Communication dans un congrès
hal-02748125v1
|
|
Chronic administration of ivermectin leads to a decrease of its concentration in the host12. International Congress of the European Association for Veterinary Pharmacology and Toxicology (EAVPT 2012), Jul 2012, Noordwijkerhout, Netherlands. 182 p
Communication dans un congrès
hal-02748957v1
|
|
Differential neurotoxicity of ivermectin and moxidectin in mammals12. International Congress of the European Association for Veterinary Pharmacology and Toxicology (EAVPT 2012), Jul 2012, Noordwijkerhout, Netherlands. 182 p
Communication dans un congrès
hal-02748121v1
|
|
Optimizing anthelmintic combinations to counter anthelmintic resistanceConference of the World Association for the Advancement of Veterinary Parasitology, Saisissez le nom du laboratoire, du service ou du département., Ville service., Aug 2011, Buenos Aires, Argentina
Communication dans un congrès
hal-02802149v1
|
|
Interaction of anthelminthics with ABC transportersSymposium on Membrane Ion Channels in Helminth Parasites, Resistance and Site of Action for Anthelmintics, Saisissez le nom du laboratoire, du service ou du département., Ville service., Dec 2011
Communication dans un congrès
hal-02803051v1
|
|
Pharmacocinétique de l'éprinomectine chez les souris déficientes en P-gp : comparaison avec l'ivermectine et la moxidectineJournées d’Animation Scientifique du Département Santé Animale, 2009, Port d'Albret, France. pp.Inconnu
Communication dans un congrès
hal-02822598v1
|
|
WP6 - Control of P-glycoprotein (Pgp) in both host and parasites for an improvement of anthelmintic treatment.PARASOL - Sixth framework programme of the E.U. (Project FOOD-CT-2005-022851) - Novel solutions for the sustainable control of nematodes in ruminants, 2009, Edinburgh, United Kingdom. n.p
Communication dans un congrès
hal-02823130v1
|
|
Influence of obesity on the pharmacokinetics of anthelmintic macrocyclic lactones in dogs11th International congress of the European Association for Veterinary Pharmacology and Toxicology, 2009, Leipzig, Germany
Communication dans un congrès
hal-02752015v1
|
|
The anthelmintic ivermectin: a substrate of Breast-Cancer Resistant Protein (BCRP)22nd World Association for the Advancement of Veterinary Parasitology Conference - WAAVP 2009, 2009, Calgary, Canada. pp.Inconnu
Communication dans un congrès
hal-02821732v1
|
|
Disposition of eprinomectin in P-gp deficient mice: a comparison with ivermectin and moxidectin22nd World Association for the Advancement of Veterinary Parasitology Conference - WAAVP 2009, 2009, Calgary, Canada. pp.Inconnu
Communication dans un congrès
hal-02815515v1
|
|
Investigations into the effects of p-glycoprotein and/or cytochrom P450 inhibitors on the phenotype responses of various developmental stages of ovine nematodes21st International Conference of the World Association for the Advancement of Veterinary Parasitology (WAAVP), 2007, Ghent, Belgium. pp.Inconnu
Communication dans un congrès
hal-02814112v1
|
|
Interaction of macrocyclic lactones (MLs) with multidrug resistance transporters21st International Conference of the World Association for the Advancement of Veterinary Parasitology (WAAVP), 2007, Ghent, Belgium. pp.Inconnu
Communication dans un congrès
hal-02815063v1
|
|
Interaction of MLs with ABC transportersInvited by SOLVO Biotechnology, 2006, Budapest, Hungary. pp.Inconnu
Communication dans un congrès
hal-02811791v1
|
|
The role of drug transporters in the disposition of milbemycins and avermectinsEAVPT, 2006, Turin, Italy. pp.Inconnu
Communication dans un congrès
hal-02815213v1
|
|
Influence of anthelmintic drugs on P-glycoprotein transport activity in mdr1-LLC-PK1 cellsEAVPT, 2006, Turin, Italy. pp.Inconnu
Communication dans un congrès
hal-02812336v1
|
|
Rôle des ABC transporteurs dans le devenir des lactones macrocycliques dans l'organismeJournées francophones sur les transporteurs ABC, 2006, Paris, France. pp.Inconnu
Communication dans un congrès
hal-02811820v1
|
|
Differences between ivermectin and moxidectin related to their affinities for multidrug resistance proteins (MRP1, 2 and 3)10e Congrès international de l’EAVPT, 2006, Turin, Italy. pp.Inconnu
Communication dans un congrès
hal-02816593v1
|
|
Differences between ivermectin and moxidectin related to their affinities for multidrug resistance proteins (MRP1, 2, and 3)Inconnu, 2006, pp.Inconnu
Communication dans un congrès
hal-02814340v1
|
|
Intestinal lymphatic transport of moxidectin in conscious lymph duct-cannulated dogsEUFEPS Conferences 3rd World Conference on Drug Absorption Transport and delivery, 2004, Barcelona, Spain. pp.Inconnu
Communication dans un congrès
hal-02827582v1
|
|
Effect of route of administration and formulation on ivermectin bioavailability in Chinese cattleINCO Project nICA42000-30036 meeting, 2004, Shangai, China. pp.Inconnu
Communication dans un congrès
hal-02825390v1
|
|
Chemotherapy improvement for hypodermosisINCO Project nICA42000-30036 meeting, 2004, Shangai, China. pp.Inconnu
Communication dans un congrès
hal-02825185v1
|
|
Influence of hypercholesterolemia on disposition of moxidectin in a rabbit modelEUFEPS Conferences 3rd World Conference on Drug Absorption Transport and delivery, 2004, Barcelona, Spain. pp.Inconnu
Communication dans un congrès
hal-02827470v1
|
|
Influence of the macrocyclic lactones on the P-glycoprotein function on P-gp overexpressing cellsEuropean Federation for Pharmaceutical Sciences Conference, 2004, Copenhagen, Denmark. pp.Inconnu
Communication dans un congrès
hal-02830010v1
|
|
Hypodermosis control : determination of dose and route of administration of ivermectin microdosis to goatINCO Project nICA42000-30036 meeting, 2004, Shangai, China. pp.Inconnu
Communication dans un congrès
hal-02825675v1
|
|
Eprinomectin in dairy goats : assessment of an optimal dosage8th International Conference on Goats, 2004, Pretoria, South Africa. pp.Inconnu
Communication dans un congrès
hal-02825263v1
|
|
Improvement of ML's treatment by control of P-glycoprotein in the hostCOST - B16, 2004, Paris, France. pp.Inconnu
Communication dans un congrès
hal-02825235v1
|
|
Use of reversing agents of P-glycoprotein to increase the systematic availability of macrocyclic lactones : a promising tool19th International Conference of the World Association for the Advancement of Veterinary Parasitology, 2003, New Orleans, United States. pp.Inconnu
Communication dans un congrès
hal-02825262v1
|
|
Role of the P-glycoprotein in the cellular eflux of macrocyclic lactones : influence of interfering agents9th EAVPT Congress, 2003, Lisbon, Portugal. pp.Inconnu
Communication dans un congrès
hal-02828145v1
|
|
Binding of ivermectin and moxidectin to the plasma lipoproteins9th EAVPT Congress, 2003, Lisbon, Portugal. pp.Inconnu
Communication dans un congrès
hal-02828011v1
|
|
Putative prediction of macrocyclic lactones in vivo-disposition using an original pharmacological parameter [Vp50] obtained from transport experiments in P-glycoprotein-expressing cells19th International Conference of the World Association for the Advancement of Veterinary Parasitology (WAAVP), 2003, New Orleans, United States. pp.Inconnu
Communication dans un congrès
hal-02829726v1
|
|
Ecotoxicity of antiparasitics: optimization of the use of pharmaceutical forms of ivermectin and its analogues[Rapport de recherche] ASI0001393, INRAE. 2021, pp.20
Rapport
hal-03294640v1
|
|
Le contrôle du varron par l'ivermectine : éradication de l’hypodermose bovine[Rapport de recherche] 1396, INRAE. 2021, pp.17
Rapport
hal-03292187v1
|
|
Création de tomates de qualité pour le frais et l’industrie : F1 GARANCE et F1 TERRADOU[Rapport Technique] INRA. 2015
Rapport
hal-02794423v1
|
|
Antiparasitaires : homme et animal, même combat !2020
Autre publication scientifique
hal-02952479v1
|
|
Deux mutations rares chez l'homme responsables de la toxicité du traitement contre la gâle2020
Autre publication scientifique
hal-02952475v1
|